PharmacoEconomics & Outcomes News

, Volume 770, Issue 1, pp 18–18 | Cite as

Lisdexamphetamine cost effective for ADHD in UK adults

Clinical study
  • 12 Downloads

Reference

  1. Zimovetz EA, et al. A cost-effectiveness analysis of lisdexamfetamine dimesylate in the treatment of adults with attention-deficit/hyperactivity disorder in the UK. Journal of Health Economics : 16 Jan 2017. Available from: URL:  http://dx.doi.org/10.1007/s10198-016-0864-4

Copyright information

© Springer International Publishing Switzerland 2017

Personalised recommendations